Latest Market Trends and Industry Insights

Medical diagnostics render solution to cater to greater health challenges which the general public faces, like, the fight against antimicrobial resistance, and sepsis prevention and surveillance. Furthermore, they have a prime role in the control, prevention and surveillance of pandemics. These tests examine biological samples such as saliva, blood, skin, urine, etc., taken from patients; determine the existence of any type of viruses, bacteria, parasites or fungi along with any other secreted substances by an individual. Medical diagnostics is a process of carrying out diagnostic tests by making use of analysing reagents, apparatuses and systems to ascertain a pathological condition or a disease in a laboratory. The Medical Diagnostics Market has remarked significant demand in the recent years and is foreseen to grow tremendously in the forthcoming years. The global market for medical diagnostics is predicted to capture major share in the future as these diagnostic tools are user-friendly and are superiorly accessible. The increasing acceptance and use of point-of-care (POC) tests and with the introduction of biomarker-based tests globally, this market is sure to gain popularity during the forecast period. Patients and healthcare facilities are working towards empowering early detection of diseases by currently decentralizing their facilities, to provide medical services remotely and at controlled costs. As these diagnostic tools are easily available and simple to use, the market for medical diagnostics is anticipated to gain significant traction over the forecast period.

Product Outlook and Trend Analysis

The product based segment of medical diagnostic market has been segmented into POC diagnostics, Molecular diagnostics, Hematology devices, Tissue diagnostics and Clinical microbiology systems. It is estimated that the POC testing segment is anticipated to grow at the most elevated CAGR over the forecast period. This segment is anticipated to grow at a rate of approximately 12% due to its ability to curtail the clinical operating time and reduce the number of visits to the clinic.

Competitive Insights

The leading players in the market are Biomerieux, Beckman Coulter Diagnostics, Roche Qiagen, Amgenix International, BD, Cepheid, DiagCor, Hologic, Life Technologies, Randox Laboratories and Span Diagnostics. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

Regional Outlook and Trend Analysis

North America held the biggest share of the overall industry based on income attributable to expanding geriatric populace base, rising awareness in patients towards the importance of lab tests, accessibility of cost effective tests associated with chronic sicknesses, for example, hepatitis C and AIDS. Developing interest for healthcare benefits in developing markets and the nearness of highly neglected clinical testing needs have brought about advancement of beneficial opportunities for development of research facility testing market in rising economies, for example, China and India.

The Medical Diagnostic Market is segmented as follows-

By Product:

POC diagnostics

Molecular diagnostics

Hematology devices

Tissue diagnostics

Clinical microbiology systems

By Region

North America U.S. Canada Mexico

Europe Germany UK France Russia Italy Rest of Europe

Asia-Pacific China Japan South Korea India Southeast Asia Rest of Asia-Pacific

South America Brazil Argentina Columbia South Africa Rest of South America

Middle East and Africa Saudi Arabia UAE Egypt Nigeria South Africa Rest of MEA



Some of the key questions answered by the report are: